GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 8 filers reported holding GLAXOSMITHKLINE PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $24,000 | -4.0% | 534 | -2.9% | 0.01% | +11.1% |
| Q4 2021 | $25,000 | +19.0% | 550 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $21,000 | -8.7% | 550 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $23,000 | +228.6% | 550 | +175.0% | 0.01% | +200.0% |
| Q1 2021 | $7,000 | -53.3% | 200 | -51.0% | 0.00% | -62.5% |
| Q4 2020 | $15,000 | 0.0% | 408 | -1.7% | 0.01% | 0.0% |
| Q3 2020 | $15,000 | +15.4% | 415 | +30.5% | 0.01% | 0.0% |
| Q2 2020 | $13,000 | 0.0% | 318 | 0.0% | 0.01% | -11.1% |
| Q1 2020 | $13,000 | +85.7% | 318 | +122.4% | 0.01% | +80.0% |
| Q4 2019 | $7,000 | +133.3% | 143 | +138.3% | 0.01% | +150.0% |
| Q1 2019 | $3,000 | +50.0% | 60 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $2,000 | 0.0% | 60 | 0.0% | 0.00% | +100.0% |
| Q3 2018 | $2,000 | -81.8% | 60 | -76.6% | 0.00% | -85.7% |
| Q2 2018 | $11,000 | +10.0% | 256 | -0.8% | 0.01% | 0.0% |
| Q1 2018 | $10,000 | +11.1% | 258 | -1.1% | 0.01% | 0.0% |
| Q4 2017 | $9,000 | – | 261 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |